letrozole has been researched along with finasteride in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bergeron, JM; Crews, D | 1 |
| Reddy, DS | 1 |
| Corradi, LS; Góes, RM; Taboga, SR; Vilamaior, PS | 1 |
| Ahmadiani, A; Amini, H; Moradi-Azani, M | 1 |
| Frondaroli, A; Grassi, S; Pettorossi, VE | 1 |
| Eisermann, K; Ma, HM; Masoodi, KZ; Nelson, JB; Nguyen, HM; O'Malley, K; Parikh, RA; Pascal, LE; Ramos Garcia, R; Shevrin, DH; Vessella, RL; Wang, Y; Wang, Z | 1 |
| Calabresi, P; Di Mauro, M; Grassi, S; Pettorossi, VE; Tozzi, A | 1 |
| Brady, PH; Gin, GT; Rosenblum, E; Wilkinson, LD | 1 |
1 review(s) available for letrozole and finasteride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for letrozole and finasteride
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Role of reductase and aromatase in sex determination in the red-eared slider (Trachemys scripta), a turtle with temperature-dependent sex determination.
Topics: Animals; Aromatase; Aromatase Inhibitors; Azasteroids; Dihydrotestosterone; Dose-Response Relationship, Drug; Fadrozole; Female; Finasteride; Letrozole; Male; Nitriles; Oxidoreductases; Sex Determination Analysis; Sex Ratio; Temperature; Testosterone; Triazoles; Turtles | 1994 |
Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol.
Topics: Androstane-3,17-diol; Animals; Aromatase Inhibitors; Chromatography; Convulsants; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Finasteride; Hippocampus; Letrozole; Male; Mass Spectrometry; Mice; Nitriles; Organ Culture Techniques; Patch-Clamp Techniques; Pentylenetetrazole; Rats; Receptors, GABA-A; Seizures; Testosterone; Triazoles | 2004 |
Increased androgen receptor and remodeling in the prostatic stroma after the inhibition of 5-alpha reductase and aromatase in gerbil ventral prostate.
Topics: Animals; Aromatase; Cholestenone 5 alpha-Reductase; Enzyme Inhibitors; Estradiol; Finasteride; Gerbillinae; Histocytochemistry; Immunohistochemistry; Letrozole; Male; Nitriles; Prostate; Receptors, Androgen; Testosterone; Triazoles | 2009 |
Increase in formalin-induced tonic pain by 5alpha-reductase and aromatase inhibition in female rats.
Topics: 5-alpha Reductase Inhibitors; Analgesics, Opioid; Animals; Aromatase Inhibitors; Drug Synergism; Female; Finasteride; Formaldehyde; Letrozole; Morphine; Nitriles; Ovariectomy; Pain; Pain Measurement; Rats; Rats, Wistar; Triazoles | 2011 |
Cyclic estrogenic fluctuation influences synaptic transmission of the medial vestibular nuclei in female rats.
Topics: 5-alpha Reductase Inhibitors; Animals; Aromatase Inhibitors; Diestrus; Electric Stimulation; Estradiol; Female; Finasteride; In Vitro Techniques; Letrozole; Nitriles; Proestrus; Rats; Rats, Wistar; Synaptic Transmission; Triazoles; Vestibular Nuclei | 2011 |
5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models.
Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Cell Line, Tumor; Cell Proliferation; Dutasteride; Finasteride; Humans; Immunohistochemistry; Letrozole; Male; Mice; Mice, Nude; Mice, SCID; Nitriles; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Testosterone; Triazoles | 2013 |
Different synaptic stimulation patterns influence the local androgenic and estrogenic neurosteroid availability triggering hippocampal synaptic plasticity in the male rat.
Topics: 5-alpha Reductase Inhibitors; Animals; Aromatase Inhibitors; Estradiol; Finasteride; Hippocampus; Letrozole; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Nitriles; Rats; Rats, Wistar; Synaptic Potentials; Testosterone; Triazoles | 2017 |
Female Pelvic Conditions: Polycystic Ovary Syndrome.
Topics: Acne Vulgaris; Anovulation; Female; Finasteride; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Infertility; Letrozole; Male; Obesity; Polycystic Ovary Syndrome; Spironolactone; Weight Loss | 2022 |